학술논문
High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma
Document Type
Article
Author
Source
In JHEP Reports April 2023 5(4)
Subject
Language
ISSN
2589-5559